帕金森病脑深部电刺激电极翻修或再植入后的结局
该研究回顾了作者所在机构6年内帕金森病患者脑深部电刺激(DBS)颅内电极取出、翻修或再植入的数据,最终纳入25例患者共34次电极取出,其中13例患者18根电极在取出后重新植入。因疗效不佳行翻修的患者术后运动评分显著改善(p=0.025)。因疗效不佳再植入的患者新电极位置与旧位置的平均向量距离为2.73 mm(SD 1.31 mm),因感染再植入者为1.67 mm(SD 0.83 mm)。作者认为因疗效不佳再植入可能带来显著获益,感染后再植入似乎可行且总体安全。
要点
- 因疗效不佳行DBS电极翻修的患者术后运动评分显著改善(p=0.025)。
- 因疗效不佳再植入者新旧电极平均向量距离为2.73 mm(SD 1.31 mm),感染者为1.67 mm(SD 0.83 mm)。
- 作者认为感染后再植入似乎可行且总体安全。
核心结论
- 因疗效不佳行再植入手术的帕金森病患者可能获得显著获益。
- 手术感染后再植入似乎可行且总体安全。
研究设计与样本
- 回顾性分析作者所在机构6年内帕金森病患者DBS颅内电极取出、翻修或再植入的数据,最终样本包括25例患者共34次电极取出,其中13例患者18根电极在取出后重新植入。
主要发现
- 因疗效不佳行翻修的患者术后运动评分显著改善(p=0.025)。
- 新电极位置与旧位置的平均向量距离为2.16 mm(SD 1.17),在前后连合线下方3.5 mm的轴位平面上测量。
- 按亚组分析,因感染再植入者平均距离为1.67 mm(SD 0.83 mm),因疗效不佳再植入者为2.73 mm(SD 1.31 mm)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The number of patients who benefit from deep brain stimulation (DBS) for Parkinson's disease (PD) has increased significantly since the therapy was first approved by the FDA. Suboptimal outcomes, infection, or device failure are risks of the procedure and may require lead removal or repositioning. The authors present here the results of their series of revision and reimplantation surgeries. METHODS: The data were reviewed from all DBS intracranial lead removals, revisions, or reimplantations among patients with PD over a 6-year period at the authors' institution. The indications for these procedures were categorized as infection, suboptimal outcome, and device failure. Motor outcomes as well as lead location were analyzed before removal and after reimplant or revision. RESULTS: The final sample included 25 patients who underwent 34 lead removals. Thirteen patients had 18 leads reimplanted after removal. There was significant improvement in the motor scores after revision surgery among the patients who had the lead revised for a suboptimal outcome (p = 0.025). The mean vector distance of the new lead location compared to the previous location was 2.16 mm (SD 1.17), measured on an axial plane 3.5 mm below the anterior commissure-posterior commissure line. When these leads were analyzed by subgroup, the mean distance was 1.67 mm (SD 0.83 mm) among patients treated for infection and 2.73 mm (SD 1.31 mm) for those with suboptimal outcomes. CONCLUSIONS: Patients with PD who undergo reimplantation surgery due to suboptimal outcome may experience significant benefits. Reimplantation after surgical infection seems feasible and overall safe.
引用
- Frizon LA, Nagel SJ, May FJ, et al. Outcomes following deep brain stimulation lead revision or reimplantation for Parkinson's disease. J Neurosurg. 2018. PMID: 29932378. doi:10.3171/2018.1.JNS171660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。